JP2018507689A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018507689A5 JP2018507689A5 JP2017542470A JP2017542470A JP2018507689A5 JP 2018507689 A5 JP2018507689 A5 JP 2018507689A5 JP 2017542470 A JP2017542470 A JP 2017542470A JP 2017542470 A JP2017542470 A JP 2017542470A JP 2018507689 A5 JP2018507689 A5 JP 2018507689A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- xaa
- linker
- seq
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201501119W | 2015-02-13 | ||
| SG10201501119W | 2015-02-13 | ||
| PCT/SG2016/050079 WO2016130092A1 (en) | 2015-02-13 | 2016-02-15 | Non-membrane disruptive p53 activating stapled peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018507689A JP2018507689A (ja) | 2018-03-22 |
| JP2018507689A5 true JP2018507689A5 (enExample) | 2019-03-28 |
| JP7028643B2 JP7028643B2 (ja) | 2022-03-02 |
Family
ID=56614951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017542470A Active JP7028643B2 (ja) | 2015-02-13 | 2016-02-15 | 膜を破壊しないｐ５３活性化ステープルペプチド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11319344B2 (enExample) |
| EP (1) | EP3256484B1 (enExample) |
| JP (1) | JP7028643B2 (enExample) |
| CN (1) | CN107531759B (enExample) |
| SG (1) | SG11201706562QA (enExample) |
| WO (1) | WO2016130092A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020027585A2 (ko) * | 2018-07-31 | 2020-02-06 | 주식회사 레모넥스 | 폴리펩타이드 전달용 조성물 |
| US20210309763A1 (en) * | 2018-07-31 | 2021-10-07 | Lemonex Inc. | Polypeptide delivery composition |
| WO2021112614A1 (ko) * | 2019-12-05 | 2021-06-10 | 아주대학교산학협력단 | 펩타이드 또는 이의 혼합물을 유효성분으로 함유하는 베체트병 또는 류마티스 관절염 예방 또는 치료용 약학조성물 |
| CN111613275B (zh) * | 2020-05-26 | 2021-03-16 | 中国海洋大学 | 一种基于rmsd多特征的药物分子动力学结果分析方法 |
| WO2022081827A1 (en) | 2020-10-14 | 2022-04-21 | Dana-Farber Cancer Institute, Inc. | Chimeric conjugates for degradation of viral and host proteins and methods of use |
| WO2024051616A1 (zh) * | 2022-09-09 | 2024-03-14 | 湖南大学 | 一种多肽及其制备方法和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8343760B2 (en) * | 2008-06-05 | 2013-01-01 | University Of Maryland, Baltimore | p53 activator peptides |
| PE20120630A1 (es) * | 2009-08-17 | 2012-05-26 | Roche Glycart Ag | Inmunoconjugados dirigidos |
| US20120328692A1 (en) | 2011-06-24 | 2012-12-27 | University Of Maryland, Baltimore | Potent d-peptide antagonists of mdm2 and mdmx for anticancer therapy |
| EP2904000A4 (en) * | 2012-10-01 | 2016-04-20 | Agency Science Tech & Res | PEPTIDES AND METHOD FOR THE TREATMENT OF CANCER |
| EP2991665A4 (en) * | 2013-03-13 | 2016-11-09 | Harvard College | STACKED AND GRAFTED POLYPEPTIDES AND USES THEREOF |
| US20150010932A1 (en) * | 2013-07-02 | 2015-01-08 | Salk Institute For Biological Studies | Methods for assaying protein-protein interactions |
-
2016
- 2016-02-15 US US15/550,766 patent/US11319344B2/en active Active
- 2016-02-15 JP JP2017542470A patent/JP7028643B2/ja active Active
- 2016-02-15 CN CN201680021720.3A patent/CN107531759B/zh active Active
- 2016-02-15 EP EP16749553.0A patent/EP3256484B1/en active Active
- 2016-02-15 WO PCT/SG2016/050079 patent/WO2016130092A1/en not_active Ceased
- 2016-02-15 SG SG11201706562QA patent/SG11201706562QA/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018507689A5 (enExample) | ||
| US20210261620A1 (en) | PEPTIDE LIGANDS FOR BINDING TO EphA2 | |
| CN112585156A (zh) | 用于结合psma的肽配体 | |
| EP2035041B1 (en) | Conjugates for innate immunotherapy of cancer | |
| Glaffig et al. | A fully synthetic glycopeptide antitumor vaccine based on multiple antigen presentation on a hyperbranched polymer | |
| RU2013137868A (ru) | Меченые альдегидом полипептиды иммуноглобулина и способы их применения | |
| JP2020502051A5 (enExample) | ||
| JP2015519339A5 (enExample) | ||
| CN107148425A (zh) | 对mt1‑mmp特异性的双环肽配体 | |
| CN112533937A (zh) | 用于结合cd38的肽配体 | |
| EP4055037A1 (en) | Il-2r beta gamma c binding compounds | |
| JP2014520120A5 (enExample) | ||
| KR101972012B1 (ko) | 세포 투과성 스테이플 펩타이드, 이의 제조방법 및 그 용도 | |
| JP2014166186A5 (enExample) | ||
| KR20180042442A (ko) | 방사성표지 ｈｅｒ２ 결합 펩티드 | |
| CN112585155A (zh) | 用于结合il-17的肽配体 | |
| CN104130315A (zh) | 一种特异靶向her2蛋白的多肽 | |
| Hu et al. | Targeted modification of the cationic anticancer peptide HPRP-A1 with iRGD to improve specificity, penetration, and tumor-tissue accumulation | |
| CN105693860B (zh) | 特异性靶向her2蛋白的多肽及其应用 | |
| CN105085632A (zh) | 一种特异靶向egfr蛋白的多肽及其应用 | |
| CN111971060A (zh) | 募集抗体并靶向肿瘤细胞的双功能分子 | |
| Nezir et al. | Synthesis and evaluation of tumor-homing peptides for targeting prostate cancer | |
| JP2015512247A5 (enExample) | ||
| US20250127887A1 (en) | Self-Assembling Nanoparticles Based On Amphiphilic Peptides | |
| CN105085631A (zh) | 一种特异靶向her2蛋白的多肽及其应用 |